Accéder au contenu
Merck

Kindlin-1 contributes to EGF-induced re-epithelialization in skin wound healing.

International journal of molecular medicine (2017-03-16)
Congcong Shen, Linlin Sun, Ningwen Zhu, Fazhi Qi
RÉSUMÉ

The commercial use of epidermal growth factor (EGF) is extensive and has been shown to be effective for skin wound healing in clinical practice. There is evidence to indicate that the topical administration of EGF significantly accelerates re-epithelialization by promoting keratinocyte mitogenesis and migration following acute injury; however, the mechanisms involved remain to be elucidated. Thus, in this study, we focused on Kindlin-1, a four-point-one, ezrin, radixin, moesin (FERM)-domain-containing adaptor protein, and report its contribution to EGF-induced re-epithelialization in skin wound healing. In tissue samples, the expression of Kindlin-1 was induced upon EGF treatment compared to that in the natural healing group. In immortalized human keratinocytes (HaCaT cells), we further proved that Kindlin-1 was necessary for mediating EGF-induced activation signals, including integrin β1 activation, focal adhesion kinase (FAK) phosphorylation and actin re-organization, which finally led to enhanced cell proliferation and migration. These results indicate that Kindlin-1 is essential in EGF-induced re-epithelialization in skin wound healing and provide additional rationale for the clinical application of EGF in the treatment of acute wounds.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-intégrine β1 activée, clone HUTS-4, sans azoture, clone HUTS-4, Chemicon®, from mouse
Sigma-Aldrich
Anti-Kindlin-1 antibody, Mouse monoclonal, clone KN-4, purified from hybridoma cell culture